Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality.
OBJECTIVE
Positive surgical margins in men undergoing radical prostatectomy for prostate cancer are associated with an increased risk of biochemical recurrence. Few data are available on the role of positive surgical margins in prostate cancer specific mortality. Using a large, population based national cancer registry we evaluated the risk of prostate cancer specific mortality associated with margin status.


METHODS
The SEER cancer registry data for patients diagnosed between 1998 and 2006 were used to identify men undergoing radical prostatectomy for prostate cancer. Margin status, pathological stage, Gleason grade and postoperative radiation therapy were recorded along with demographic data. Multivariate Cox regression analysis was used to estimate the risk of prostate cancer specific mortality associated with positive surgical margins.


RESULTS
A total of 65,633 patients comprised the cohort in which 291 (0.44%) prostate cancer specific deaths occurred during an average followup of 50 months. Positive surgical margins were reported in 21.2% of cases and were more common in pT3a than pT2 tumors (44% vs 18%, p <0.001) and higher grade tumors (28% vs 18%, p <0.001). The 7-year disease specific survival rates for those at highest risk for prostate cancer specific mortality (higher grade pT3a) were 97.6% for cases with negative surgical margins and 92.4% for those with positive surgical margins. Positive surgical margins were associated with a 2.6-fold increased unadjusted risk of prostate cancer specific mortality (HR 2.55, 95% CI 2.02-3.21). Positive surgical margins remained an independent predictor of prostate cancer specific mortality on multivariate analysis (HR 1.70, 95% CI 1.32-2.18).


CONCLUSIONS
These data demonstrate the independent role of positive surgical margins in prostate cancer specific mortality. These findings support the importance of optimizing surgical techniques to achieve a sound oncological surgical outcome with negative surgical margins when possible.
Wright
Jonathan L
JL
Department of Urology, University of Washington School of Medicine, Seattle, Washington, USA. jlwright@u.washington.edu
Dalkin
Bruce L
BL
True
Lawrence D
LD
Ellis
William J
WJ
Stanford
Janet L
JL
Lange
Paul H
PH
Lin
Daniel W
DW
D000368:Aged; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000401:mortality* / Q000473:pathology* / Q000601:surgery; D012307:Risk Factors
Hum Pathol. 2001 May;32(5):494-9
11381367
Urology. 1999 Oct;54(4):682-8
10510928
J Urol. 2005 Sep;174(3):903-7
16093984
Cancer. 2009 Jan 15;115(2):303-10
19025977
Am J Surg Pathol. 2008 Nov;32(11):1709-14
18769336
J Urol. 2004 Oct;172(4 Pt 1):1328-32
15371834
Urology. 2005 Dec;66(6):1245-50
16360451
N Engl J Med. 2005 May 12;352(19):1977-84
15888698
J Urol. 2009 Feb;181(2):601-7; discussion 607-8
19084864
J Clin Oncol. 2007 Sep 20;25(27):4178-86
17878474
Urology. 2007 Jun;69(6):1095-101
17572194
J Urol. 2005 May;173(5):1572-6
15821488
Eur Urol. 2008 Jan;53(1):6-9
17764823
Eur Urol. 2009 Jan;55(1):87-99
18838211
Am J Surg Pathol. 2008 Oct;32(10):1503-12
18708939
J Urol. 2005 Jun;173(6):1938-42
15879786
Urology. 2007 Nov;70(5):965-9
18068455
J Urol. 2006 Jan;175(1):140-4; discussion 144-5
16406892
Cancer. 2008 Mar 15;112(6):1254-63
18286530
J Urol. 2004 May;171(5):1844-9; discussion 1849
15076291
Urology. 2002 Oct;60(4):670-4
12385931
J Clin Oncol. 2005 Oct 1;23(28):7005-12
16192588
BJU Int. 2008 Nov;102(10):1413-8
18537951
J Clin Oncol. 2006 Aug 20;24(24):3973-8
16921049
J Urol. 2004 Jul;172(1):129-32
15201752
JAMA. 2005 Jul 27;294(4):433-9
16046649